PDS Biotechnology Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2024: USD -34.43 M

PDS Biotechnology Corporation Operating Cash Flow is USD -34.43 M for the Trailing 12 Months (TTM) ending June 30, 2024, a 9.56% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • PDS Biotechnology Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2023 was USD -31.43 M, a 43.37% change year over year.
  • PDS Biotechnology Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending June 30, 2022 was USD -21.92 M.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities